Search results for "Proportion"

showing 10 items of 877 documents

CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.

2019

In acute heart failure (AHF) with right ventricular dysfunction, the roles of amino-terminal pro-brain natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) are poorly understood, and functional tricuspid regurgitation (TR) severity is thought to indicate a poor prognosis. We examined the prognostic abilities of NT-proBNP and CA125 according to TR status among patients with AHF.TR severity was assessed during index hospitalization (108 ± 24 h after admission) and classified as none/trivial, mild, moderate, or severe. Multivariable Cox regression analysis was performed to assess how pre-discharge CA125 and NT-proBNP were associated with long-term all-cause mortality relative t…

Malemedicine.medical_specialtyMultivariate analysismedicine.drug_classRegurgitation (circulation)030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseases030212 general & internal medicineAgedAged 80 and overHeart FailureEjection fractionProportional hazards modelbusiness.industryMembrane ProteinsStroke VolumeMiddle Agedmedicine.diseasePrognosisPeptide FragmentsTricuspid Valve InsufficiencyHeart failureCA-125 AntigenCardiologyBiomarker (medicine)FemaleCardiology and Cardiovascular MedicineIndex hospitalizationbusinessBiomarkersInternational journal of cardiology
researchProduct

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

2009

Background Acquired somatic deletions and loss-of-function mutations in one or several codons of the TET2 ( Ten-Eleven Translocation-2 ) gene were recently identified in hematopoietic cells from patients with myeloid malignancies, including myeloproliferative disorders and myelodys-plastic syndromes. The present study was designed to determine the prevalence of TET2 gene alterations in chronic myelomonocytic leukemias. Design and Methods Blood and bone marrow cells were collected from 88 patients with chronic phase chronic myelomonocytic leukemia and from 14 with acute transformation of a previously identified disease. Polymerase chain reaction analysis and direct sequencing were used to se…

Malemedicine.medical_specialtyMyeloidDNA Mutational AnalysisChronic myelomonocytic leukemiaSingle-nucleotide polymorphismKaplan-Meier EstimateGene mutationBiologymedicine.disease_causeDioxygenasesGene FrequencyMonocytosisInternal medicinehemic and lymphatic diseasesProto-Oncogene ProteinsmedicineHumansGenetic Predisposition to DiseaseLetters to the EditorAgedProportional Hazards ModelsAged 80 and overComparative Genomic HybridizationMutationHematologyLeukemia Myelomonocytic ChronicHematologyMiddle Agedmedicine.diseaseMyelodysplastic-Myeloproliferative DiseasesDNA-Binding ProteinsLeukemiamedicine.anatomical_structureImmunologyMutationFemaleOriginal Article
researchProduct

Osteoarthritis Increases the Risk of Cardiovascular Disease: Data from the Osteoarthritis Initiative

2018

Objectives: Although osteoarthritis (OA) is a common condition in older adults, the role of OA in increasing cardiovascular disease (CVD) incidence is still debated. The aim of this study was to investigate the association between OA and the onset of CVD in a large database of American adults. Design: Longitudinal. Setting: Community-dwelling. Participants: People with OA or at high risk of OA. Measurements: Osteoarthritis was defined as the presence of OA of the hand, knee, hip, back/neck or of other sites. CVD was defined as self-reported presence of heart attack, heart failure, stroke and other cerebral atherosclerotic conditions, and peripheral artery disease. Results: A total 4,265 per…

Malemedicine.medical_specialtyMyocardial InfarctionMedicine (miscellaneous)OsteoarthritisDiseaseOsteoarthritis HipPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRisk Factorscardiovascular diseaseInternal medicineOsteoarthritisEpidemiologymedicineHumansOsteoarthritis cardiovascular disease epidemiologyLongitudinal StudiesObesity030212 general & internal medicinecardiovascular disease; epidemiology; Osteoarthritis; Medicine (miscellaneous); Nutrition and Dietetics; Geriatrics and GerontologyStrokeAgedProportional Hazards ModelsHeart Failure030203 arthritis & rheumatologyNutrition and Dieteticsbusiness.industryIncidence (epidemiology)ConfoundingHazard ratioMiddle AgedOsteoarthritis Kneemedicine.diseaseStrokeCardiovascular DiseasesHeart failurePhysical therapyFemaleOsteoarthritis SpineepidemiologyIndependent LivingGeriatrics and Gerontologybusiness
researchProduct

PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study.

2009

Phospholipid transferprotein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Although many studies have investigated the role of PLTP in atherogenesis, the role of PLTP in atherosclerotic diseases is unclear. We investigated the association of serum PLTP activity with the incidence of a combined endpoint (myocardial infarction and cardiovascular death) and its relation to other markers of atherosclerosis in 1,085 patients with angiographically documented coronary artery disease (CAD). In the median follow-up of 5.1 years, 156 patients had suffered from the combined endpoint of myocardial infarction or cardiovascular death including 47 of 395 p…

Malemedicine.medical_specialtyMyocardial InfarctionQD415-436Coronary Artery DiseaseKaplan-Meier Estimatelipid transfer proteinsBiochemistryCoronary artery diseasechemistry.chemical_compoundEndocrinologyRisk FactorsInternal medicinePhospholipid transfer proteinmedicineHumansMyocardial infarctionRisk factorPhospholipid Transfer Proteins3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsAgedCholesterolbusiness.industryProportional hazards modelConfoundingCase-control studyCell BiologyMiddle Agedmedicine.diseaseAtherosclerosisPrognosisEndocrinologychemistryCase-Control StudiesCardiologyFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessPatient-Oriented and Epidemiological ResearchFollow-Up StudiesJournal of lipid research
researchProduct

Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction.

2004

The additional prognostic information provided by C-reactive protein (CRP) to parameters of left ventricular function in survivors of acute myocardial infarction (AMI) was investigated in 665 patients (326 with ST elevation and 339 with non-ST elevation). Cox multivariable analysis identified the following predictors of 6-month cardiac death: age (per 5 years hazard ratio [HR] 1.2, 95% confidence interval [CI] 1.1 to 1.4, p = 0.004), Killip class >I at presentation (HR 2.4, 95% CI 1.3 to 4.5, p = 0.0001), a reduced ejection fraction (per 5% HR 1.3, 95% CI 1.2 to 1.4, p = 0.0001), and greater CRP (per 5 mg/L HR 1.02, 95% CI 1.01 to 1.04, p = 0.02); the C-index of the model was 0.77 without a…

Malemedicine.medical_specialtyMyocardial InfarctionRisk AssessmentVentricular Dysfunction LeftPredictive Value of TestsInternal medicineMedicineHumansMyocardial infarctionKillip classAgedProportional Hazards ModelsEjection fractionChi-Square Distributionbiologybusiness.industryProportional hazards modelST elevationHazard ratioC-reactive proteinmedicine.diseasePrognosisConfidence intervalC-Reactive ProteinMultivariate AnalysisCardiologybiology.proteinFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesThe American journal of cardiology
researchProduct

Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.

2009

Objective: To investigate long-term outcomes of unprotected left main coronary artery (ULMCA) disease treatment using drug-eluting stents (DES). Background: In several studies, DES implantation in ULMCA appeared safe and effective at mid-term; however, to date, there is limited long-term data. Methods: All consecutive patients undergoing sirolimus- or paclitaxel-eluting stent implantation in ULMCA disease at a single institution were evaluated. The primary endpoint was long-term major adverse cardiac events (MACE) defined as cardiac death, nonfatal myocardial infarction, or target lesion revascularization (TLR). Stent thrombosis (ST), according to Academic Research Consortium definitions, w…

Malemedicine.medical_specialtyPaclitaxelmedicine.medical_treatmentCoronary Artery DiseaseCoronary AngiographyRestenosisRecurrenceInternal medicineLong-term outcomes.medicineClinical endpointHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionSurvival rateAgedProportional Hazards ModelsSirolimusChi-Square Distributionbusiness.industryHazard ratioEuroSCOREDrug-Eluting StentsGeneral MedicineLeft main coronary arterymedicine.diseaseSurgeryTreatment OutcomeDrug-eluting stentCardiologyFemaleDrug-eluting stentCardiology and Cardiovascular MedicinebusinessMaceFollow-Up StudiesCatheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions
researchProduct

Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease

2001

Background —Vascular cell adhesion molecule (VCAM)-1, intercellular adhesion molecule (ICAM)-1, and E-selectin mediate adhesion and transmigration of leukocytes to the vascular endothelial wall and may promote plaque growth and instability. In a prospective study, we evaluated the effect of soluble adhesion molecules on the risk of future cardiovascular events among patients with angiographically documented coronary artery disease (CAD). Methods and Results —We obtained baseline samples from a prospective cohort of 1246 patients with CAD. Besides various markers of inflammation, soluble VCAM-1 (sVCAM-1), sICAM-1, and sE-selectin were determined. Follow-up information on cardiovascular even…

Malemedicine.medical_specialtyPathologyIntercellular Adhesion Molecule-1Vascular Cell Adhesion Molecule-1Coronary DiseaseInflammationSensitivity and SpecificityGastroenterologyCohort StudiesCoronary artery diseasePredictive Value of TestsRisk FactorsGermanyPhysiology (medical)Internal medicineE-selectinmedicineHumansProspective StudiesProspective cohort studyAgedProportional Hazards ModelsbiologyCell adhesion moleculebusiness.industryMiddle AgedIntercellular Adhesion Molecule-1medicine.diseaseIntercellular adhesion moleculeThrombosisSurvival RateC-Reactive Proteinbiology.proteinFemalemedicine.symptomE-SelectinCardiology and Cardiovascular MedicinebusinessCell Adhesion MoleculesFollow-Up StudiesCirculation
researchProduct

Survival of Mycosis Fungoides in Patients in the Southeast of England

2004

<i>Background:</i> Mycosis fungoides (MF) is the most common skin lymphoma. The aetiology of MF remains unknown, and no therapy has to date significantly altered patient survival. <i>Objective:</i> The present study examines trends in survival of MF patients in a well-defined population-based disease group, namely patients registered over a 40-year period at the Thames Cancer Registry, Southeast England. <i>Methods:</i> The Thames Cancer Registry is a population-based registry, covering a population of approximately 14 million people. Data were taken from the Surveillance, Epidemiology and End Results cancer registry programme and the National Centre for …

Malemedicine.medical_specialtyPathologySkin NeoplasmsAntineoplastic Agents HormonalDermatologyCohort StudiesMycosis FungoidesSex FactorsResidence CharacteristicsEpidemiologymedicineHumansSezary SyndromeIn patientRegistriesSurvival rateAgedProportional Hazards ModelsMycosis fungoidesbusiness.industryProportional hazards modelAge FactorsMiddle AgedPrognosismedicine.diseaseDermatologyPeripheral T-cell lymphomaLymphomaSurvival RateEnglandPopulation SurveillanceEtiologyFemalebusinessFollow-Up StudiesSEER Program
researchProduct

Associations of neuropsychiatric symptoms and antidepressant prescription with survival in Alzheimer's disease

2017

Objective Depression is associated with increased mortality in community samples. The use of antidepressant medication may also increase mortality, however, it is still unclear whether taking antidepressants before or after a diagnosis of dementia influences survival. Design Retrospective. Setting A cohort with a diagnosis of Alzheimer disease (AD) from a large mental health and dementia care database in South London, linked to hospitalization and mortality data. Participants Mild dementia (Mini-Mental State Examination ≥18/30) at the point of diagnosis. Measurements We ascertained antidepressant prescription, either in the 6 months before or after dementia diagnosis, and used the HoNOS65+,…

Malemedicine.medical_specialtyPediatricsDatabases FactualDementia; antidepressants; depression; mortalityKaplan-Meier EstimateNeuropsychological TestsRisk AssessmentSeverity of Illness Index03 medical and health sciencesSex Factors0302 clinical medicineAlzheimer DiseasemedicineHumansDementia030212 general & internal medicineMedical prescriptionRisk factorPsychiatryGeneral NursingDepression (differential diagnoses)AgedProportional Hazards ModelsRetrospective StudiesAged 80 and overDepressive Disorderbusiness.industryHealth PolicyHazard ratioAge FactorsGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysismortalityAntidepressive AgentsConfidence intervalantidepressantsdepressionCohortFemaleDementiaGeriatrics and GerontologyAlzheimer's diseasebusinessdementia mortality030217 neurology & neurosurgery
researchProduct

Fifteen-year mortality of patients with asthma-COPD overlap syndrome

2016

Abstract Background The coexistence of asthma and chronic obstructive pulmonary disease (asthma–COPD overlap syndrome: ACOS) is increasingly recognized but data about its prevalence and long-term mortality are needed. Methods Prevalence of ACOS and 15-year mortality rates were assessed in 1065 subjects aged > 65 years, enrolled in the SA.R.A. study, with complete clinical, lung functional and follow-up data. Physical performance, disease-related disability, and health-related quality of life (HRQL) were also evaluated. Results ACOS was found in 11.1% of subjects (29.4% of those previously diagnosed with COPD and 19.7% of those with asthma). ACOS was positively associated with impaired physi…

Malemedicine.medical_specialtyPediatricsEpidemiologyComorbidityKaplan-Meier Estimate03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineEpidemiologymedicineInternal MedicineHumansCOPD030212 general & internal medicineFunctional abilityMortalityAsthmaAgedProportional Hazards ModelsAged 80 and overCOPDbusiness.industryMortality rateChronic obstructive pulmonary diseaseCase-control studyOverlap syndromemedicine.diseasePrognosisComorbidityAsthmarespiratory tract diseases030228 respiratory systemItalyCase-Control StudiesQuality of LifeFemalebusiness
researchProduct